IL1B and ventilator-associated pneumonia: Furthermore, in the validation cohort, a combination of IL-1β and IL-8 could be used as a biomarker test to rule out VAP with high confidence, with a NPV of 1 and a post-test probability of 0 % (95 % confidence interval 0–9.2 %).